A luminal unfolding microneedle injector for oral delivery of macromolecules

Insulin and other injectable biologic drugs have transformed the treatment of patients suffering from diabetes1,2, yet patients and healthcare providers often prefer to use and prescribe less effective orally dosed medications3-5. Compared with subcutaneously administered drugs, oral formulations cr...

Full description

Bibliographic Details
Main Authors: Abramson, Alex (Author), Caffarel Salvador, Ester (Author), Soares, Vance (Author), Minahan Jr, Daniel J (Author), Tian, Ryan Yu (Author), Lu, Xiaoya (Author), Dellal, David (David M.) (Author), Gao, Yuan (Author), Kim, Soyoung (Author), Wainer, Jacob P (Author), Collins, Joy E (Author), Tamang, Siddartha M (Author), Hayward, Alison M (Author), Yoshitake, Tadayuki (Author), Lee, Hsiang-Chieh (Author), Fujimoto, James G (Author), Fels, Johannes (Author), Frederiksen, Morten Revsgaard (Author), Rahbek, Ulrik (Author), Roxhed, Niclas (Author), Langer, Robert S (Author), Traverso, Carlo Giovanni (Author)
Other Authors: Massachusetts Institute of Technology. Department of Chemistry (Contributor), Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor), Massachusetts Institute of Technology. Division of Comparative Medicine (Contributor), Massachusetts Institute of Technology. Media Laboratory (Contributor), Massachusetts Institute of Technology. Research Laboratory of Electronics (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Springer Science and Business Media LLC, 2021-01-04T19:42:56Z.
Subjects:
Online Access:Get fulltext

Similar Items